Cognitive therapy for depression: Conceptual issues and clinical efficacy.

Hollon, Steven D.; Shelton, Richard C.; Davis, Denise D.

doi:10.1037/0022-006x.61.2.270

Cited by 94 publications

(62 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Several studies have demonstrated that cognitive behavior therapy's effects are durable and that continuing improvement may occur even after the end of treatment (57,58). These findings are consistent with evidence that cognitive behavior therapy may have enduring effects for other disorders, such as panic disorder and depression (59,60). Delayed emergence of the effects of cognitive behavior therapy was highlighted in two studies that directly compared group cognitive behavior therapy and contingency management among cocaine-dependent patients in a methadone maintenance program (61,62).…”

Section: Cognitive Behavior and Skills Training Therapiessupporting

confidence: 78%

“…This feature may be a factor in emerging evidence for the (59,60). Delayed emergence of the effects of cognitive behavior therapy was highlighted in two studies that directly compared group cognitive behavior therapy and contingency management among cocaine-dependent patients in a methadone maintenance program (61, 62).…”

Section: Cognitive Behavior and Skills Training Therapiesmentioning

confidence: 99%

See 1 more Smart Citation

Behavioral Therapies for Drug Abuse

Carroll

Onken

2005

AJP

387

232

View full text Add to dashboard Cite

The past three decades have been marked by tremendous progress in behavioral therapies for drug abuse and dependence, as well as advances in the conceptualization of approaches to development of behavioral therapies. Cognitive behavior therapy, contingency management, couples and family therapy, and a variety of other types of behavioral treatment have been shown to be potent interventions for several forms of drug addiction, and scientific progress has also been greatly facilitated by the articulation of a systematic approach to the development, evaluation, and dissemination of behavioral therapies. The authors review recent progress in strategies for the development of behavioral therapies for drug and alcohol abuse and dependence and discuss the range of effective behavioral therapies that are currently available.Before the advent of research on treatments derived from operant and classic behaviorism, there was little indication that any form of psychosocial treatment was effective for any type of mental disorder (1-3). Research on behavioral therapies flourished with the adoption of the technology model (4, 5), which sought to systematize these therapies and the experimental methods through which they could be evaluated to achieve a level of methodological rigor on a par with the standards for pharmacological research (6,7). By the mid to late 1980s, there were a number of behavioral treatments that had been shown to be efficacious in the treatment of a variety of mental disorders, including depressive, panic, and obsessive-compulsive disorders. However, the methodological rigor and specificity that were characteristic of these studies were not yet apparent in drug abuse treatment studies, with a few exceptions (8). Although behavioral approaches were universally available in drug abuse treatment programs by the late 1980s (9), there was continued pessimism in the field regarding the efficacy of behavioral therapies for drug use disorders (10, 11).In the early 1990s, studies in which behavioral therapies, therapist training, study populations, and objective outcome measures were carefully specified and in which participants were randomly assigned to experimental and control or comparison conditions began to appear more frequently in the drug abuse treatment literature. The technology model facilitated the identification of effective behavioral treatments for substance use disorders as it enhanced the internal validity and replicability of research on behavioral therapies. However, the technology model also had the unanticipated effect of restricting the development of novel therapies. The stringent methodological requirements associated with the technology model (e.g., requiring investigators to have fully developed treatment manuals, therapist training protocols, and fidelity rating procedures) limited the therapies eligible for efficacy evaluation to those already developed for drug abuse and to those which could easily be adapted from other areas (e.g., alcohol and depression treatments). This res...

show abstract

Section: Cognitive Behavior and Skills Training Therapiessupporting

confidence: 78%

Section: Cognitive Behavior and Skills Training Therapiesmentioning

confidence: 99%

Behavioral Therapies for Drug Abuse

Carroll

Onken

2005

AJP

387

232

View full text Add to dashboard Cite

show abstract

“…If autobiographical memory is indeed a cognitive marker of depression as accumulating evidence seems to suggest [7,[17][18][19][20] , finding a differential change in autobiographical memory specificity according to treatment type is important as it shows that this cognitive vulnerability can be targeted through specific intervention. Successful treatment of depression not only requires a successful resolution of depressed symptoms but, more importantly, change in the underlying, stable vulnerability aspects that increase susceptibility for repeated episodes [13, 21,22] .…”

Section: Introductionmentioning

confidence: 99%

Changes in Autobiographical Memory Specificity following Cognitive Behavior Therapy and Pharmacotherapy for Major Depression

McBride¹,

Segal²,

Kennedy³

et al. 2007

Psychopathology

View full text Add to dashboard Cite

Background: An important cognitive marker of clinical depression is a reduced ability to be specific in recalling personal memories, a phenomenon coined ‘overgeneral memory’. Overgeneral memory is considered as a stable cognitive trait that is intrinsically linked with depression and independent of mood state. Previous studies show that autobiographical memory is modifiable. Sampling and Methods: This study investigated whether autobiographical memory is differentially affected by treatment type. Depressed patients were randomly assigned to receive either cognitive behavior therapy (CBT) for depression or pharmacotherapy (PHT). Results: The proportion of categoric memories decreased and the proportion of specific memories increased following both types of treatments, adding support to the view that overgeneral memory is modifiable. CBT also had a greater impact on reducing extended overgeneral memories compared to PHT. Conclusions: The results from the current study are important in that they show that overgeneral memory can be targeted and modified through brief treatment. The clinical significance of the finding that there was a greater decrease in extended memories in the CBT group is unclear.

show abstract

“…Some research has suggested that the greatest therapeutic gains in CBT are achieved in early sessions, when BA is administered (Hollon, Shelton, & Davis, 1993;Otto, Pava, & Sprich-Buckminster, 1996). In a dismantling study, Jacobson and colleagues (Jacobson et al, 1996) found that after 16 weeks of the separately identified components of CBT (i.e., behavioral activation, automatic thoughts remediation, and the full CBT regimen), all participants showed significant reductions in depressive symptoms and no significant differences in reported depression levels were observed between the three groups.…”

mentioning

confidence: 99%

Behavioral activation treatment for major depressive disorder: A pilot investigation.

Cullen¹,

Spates²,

Pagoto³

et al. 2006

The Behavior Analyst Today

View full text Add to dashboard Cite

Behavioral activation (BA) has emerged as an effective intervention for major depressive disorder. Previous research has indicated that it is as effective as the full cognitive behavioral treatment package (CBT). Conceptualized to consume fewer participant sessions, BA may be more efficient and cost-effective than CBT. With depression among the most common diagnoses in practice settings, NIMH's recent vision statement calls for continued research devoted to cost-and time-effective targeted treatment alternatives, including "behavioral activation as a more simply behavioral form of CBT" (NIMH, 2005, p. 92). The present investigation piloted a 10week individual intervention model of BA with medicated and unmedicated participants in a clinical research setting. This follows our earlier report (Porter, Spates, & Smitham, 2004) of an efficacious group-administered BA intervention. In comparison to the group intervention, end state functioning of participants in the present investigation revealed more robust symptom reductions to within the fully recovered range of functioning.

show abstract

Cognitive therapy for depression: Conceptual issues and clinical efficacy.

Cited by 94 publications

References 43 publications

Behavioral Therapies for Drug Abuse

Behavioral Therapies for Drug Abuse

Changes in Autobiographical Memory Specificity following Cognitive Behavior Therapy and Pharmacotherapy for Major Depression

Behavioral activation treatment for major depressive disorder: A pilot investigation.

Contact Info

Product

Resources

About